Fondation Hôpital Saint-Joseph: COVID-19 trials

The registry lists 23 COVID-19 studies with Fondation Hôpital Saint-Joseph as lead sponsor. 1 are open to participants now and 0 have results posted.

No phase 23(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Two-year Efficacy of Three Exercise Rehabilitation Strategies on Dyspnea in Patients Who Presented With Secondary Respiratory Distress Syndrome Secondary to Severe COVID-19 PneumoniaRecruitingNCT05890560
• Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICUStatus unknownNCT05511129
• Organizational Impact of Rapid Screening for COVID-19 by Delocalized Biology in the Birth RoomCompletedNCT05175716
• Study of the Impact of the COVID-19 Pandemic on the Management of Type 2 Diabetic Patients in a Sample in the Paris RegionCompletedNCT05175677
• TOcilizumab and Covid-19 : Risk of Severe INfectionStatus unknownNCT05017441
• Evaluation of Post-vaccination Anti-SARS-CoV-2 Serological Response in Health Care Workers With a History of COVID-19.CompletedNCT04934215
• Estimating the Prevalence of Postpartum Anxiety and Depression in the Context of the Coronavirus Disease (COVID-19) PandemicCompletedNCT04852757
• Post-Covid-19 Emotional Aspects of Hospital StaffCompletedNCT04794920
• Impact of Rapid Screening for COVID-19 in Delocalized Biology in the Emergency DepartmentCompletedNCT04786249
• Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial IntelligenceStatus unknownNCT04786197
• Diagnostic Performance of the ID Now™ COVID-19 Screening Test Versus Simplexa™ COVID-19 Direct AssayCompletedNCT04785898Not applicable
• Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive SystemCompletedNCT04616950
• Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor AntagonistCompletedNCT04594356
• Operation of the GHPSJ Clinical Ethical Reflection Assistance Group During the COVID-19 PeriodCompletedNCT04586140
• Impact of COVID-19 on the Benefit of Cardiac RehabilitationWithdrawnNCT04513964
• Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 PneumoniaTerminatedNCT04505605
• Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:Active, not recruitingNCT04488510
• Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.CompletedNCT04488484Not applicable
• Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 PneumoniaCompletedNCT04485364
• Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical VentilationCompletedNCT04468035
• Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 PandemicCompletedNCT04437719Not applicable
• Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory SymptomsCompletedNCT04420312
• One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU SettingStatus unknownNCT04373811